NEWS

Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID^® COVID -19 Rapid Antigen Test.

An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID test […]

INDICAID^® OTC COVID-19 Rapid Antigen Tests Now Available for Direct Consumer Purchase

GARDEN GROVE, CA, April 25, 2022 — PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID^® COVID-19 Rapid Antigen At-Home Test (INDICAID^® OTC) is now […]

PHASE Scientific’s COVID-19 Rapid Antigen At-Home Test Now Available Across the U.S.—Enabling the American Public to Perform the Test On-Demand

GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ — PHASE Scientific International, LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its INDICAID^® COVID-19 […]

Will Antiviral Drugs Make Significant Impact?

As PHASE Scientific USA continues to monitor the pandemic on a global scale, the spotlight has fallen on Hong Kong, where the count of daily COVID-19 cases has reached upwards of 4,000 for the very first time.

The steep surge of cases […]

The B.1.1.529 variant, termed the Omicron variant, is a highly transmissible SARS-CoV-2 variant of concern. It is important that current SARS-CoV-2 diagnostic tests remain capable of detecting the B.1.1.529 variant. This white paper describes our evaluation of the INDICAID® COVID-19 Rapid Antigen Test when used to detect specimens […]

PHASE Scientific USA’s Sales & Marketing Team welcomes the Year of the Tiger with a roaring new office in the southeast, located just north of Atlanta at 8000 Avalon Boulevard, Ste 100, Alpharetta, GA 30009, USA. The new office will help the team provide stellar sales and marketing support […]